6,486 Studies Reviewed. 85.2% of Original Studies Found Biological Effects. The Evidence is Clear.

Pulsed electromagnetic fields mediate sensory nerve regulation for bone formation in aging models

Bioeffects Seen

Authors not listed · 2025

Share:

PEMFs enhance new bone formation and innervation in aging male mice by stimulating sensory nerves to secrete Sema3A, and the Sema3A-Nrp1 pathway is central for anti-senescence effects on MSCs.

Plain English Summary

Summary written for general audiences

The study found that PEMFs increased new bone formation and nerve innervation, promoting osteogenesis and reducing adipogenesis in MSCs of aging male mice. PEMF-induced osteogenesis was impaired when sensory nerves were dysfunctional. PEMFs stimulated sensory nerves to secrete Sema3A, which acted through the Nrp1 receptor on leptin-receptor-expressing MSCs to drive osteogenesis, inhibit adipogenesis, and counteract cellular senescence. Depleting sensory nerves or knocking out Sema3A or Nrp1 abolished the bone-forming effects of PEMFs.

Why This Matters

The researchers noted that while PEMFs are known to enhance bone formation against osteoporosis, how they support bone health during aging was not understood. The authors concluded that the findings highlight the therapeutic potential of PEMFs for osteoporosis in aging males.

Cite This Study
Unknown (2025). Pulsed electromagnetic fields mediate sensory nerve regulation for bone formation in aging models.
Show BibTeX
@article{pulsed_electromagnetic_fields_mediate_sensory_nerve_regulation_for_bone_formation_in_aging_models_ce4254,
  author = {Unknown},
  title = {Pulsed electromagnetic fields mediate sensory nerve regulation for bone formation in aging models},
  year = {2025},
  
  
}

Quick Questions About This Study

PEMFs increased new bone formation and innervation, promoting osteogenesis and reducing adipogenesis in MSCs of aging male mice.
PEMF-induced osteogenesis was impaired by sensory nerve dysfunction, and depleting these nerves or knocking out Sema3A eliminated the bone-forming effects.
PEMFs stimulated sensory nerves to release Sema3A, which activated the Sema3A-Nrp1 pathway in leptin-receptor-expressing MSCs to promote osteogenesis, inhibit adipogenesis, and counter senescence.
Knocking out Nrp1 in MSCs that express the leptin receptor negated the bone-forming benefits of PEMFs.
The authors stated that the results underscore the therapeutic potential of PEMFs for treating osteoporosis in aging males.